Diagnostic efficacy of C-reactive protein and IL-6 as markers of systemic inflammation
- Authors: Zhuravleva Y.A.1, Zotova N.V.1,2, Solomatina L.V.1
-
Affiliations:
- Institute of Immunology and Physiology, Ural Branch, Russian Academy of Sciences
- B. Yeltsin Ural Federal University
- Issue: Vol 25, No 2 (2022)
- Pages: 173-180
- Section: SHORT COMMUNICATIONS
- URL: https://bakhtiniada.ru/1028-7221/article/view/120175
- DOI: https://doi.org/10.46235/1028-7221-1146-DEO
- ID: 120175
Cite item
Full Text
Abstract
Currently, despite widespread use of the terms “systemic inflammation” (SI) and “systemic inflammatory response” (SIR), there are no generally accepted criteria for their verification. These processes are often identified (which is methodologically incorrect) and associated with an increase in pro-inflammatory mediators in the blood. However, SI is a complex process that requires integral criteria including assessment of SIR as reactivity level, and additional SI phenomena, such as microthrombosis, systemic alteration, and distress of the neuroendocrine system. At the same time, there is a need to assess individual CB indicators as a more affordable alternative for medical practice than the use of complex integral indicators. Our objective was to evaluate diagnostic efficacy of CRP and IL-6 levels as markers of acute and chronic systemic inflammation.
The data of patients with acute critical conditions of infectious and non-infectious genesis were analyzed to study acute systemic inflammation (SI), data of patients with autoimmune diseases, chronic organ failure and other chronic destructive diseases were analyzed to study chronic systemic inflammation (ChrSI). SIR severity was evaluated by the calculation of an integral index – reactivity level (RL). Differentiation of the inflammatory process to either classical inflammation (CI), or systemic inflammation was carried out using the previously proposed scale of SI, verification of chronic systemic inflammation was performed by means of ChrSI scale. SI (or ChrSI) was revealed in all groups of patients, and the frequency of SI registration in patients with acute conditions increased with development of multi-organ failure. The frequency of SIR was higher in all groups, thus confirming inability to equate these disorders. ROC analysis showed that CRP level had poor diagnostic efficacy on the development of SI/ChrSI (AUC < 0.6), and IL-6 level had very good diagnostic value (AUC 0.8-0.9). The prognostic value of the markers for detecting the SIR was higher, with AUCIL-6 exceeding AUCCRP. Thus, IL-6 in many acute and chronic pathologies is sufficiently closer to integral indices than C-reactive protein with respect to diagnostic efficiency, and the dynamics of IL-6 in blood may be used to predict and evaluate complications associated with acute and chronic SI, as well as to prescribe and monitor the results of anticytokine therapy.
Full Text
##article.viewOnOriginalSite##About the authors
Yulia A. Zhuravleva
Institute of Immunology and Physiology, Ural Branch, Russian Academy of Sciences
Email: jazhur@mail.ru
PhD (Biology), Senior Research Associate, Laboratory of Inflammation Immunology
Russian Federation, 106, Pervomayskaya str., Yekaterinburg, 620049Natalia V. Zotova
Institute of Immunology and Physiology, Ural Branch, Russian Academy of Sciences; B. Yeltsin Ural Federal University
Email: zotovanat@mail.ru
PhD (Biology), Senior Research Associate, Laboratory of Inflammation Immunology, Associate Professor, Department of Medical Biochemistry and Biophysics
Russian Federation, 106, Pervomayskaya str., Yekaterinburg, 620049; YekaterinburgLiliya V. Solomatina
Institute of Immunology and Physiology, Ural Branch, Russian Academy of Sciences
Author for correspondence.
Email: slv10@list.ru
PhD (Medicine), Senior Research Associate, Laboratory of Inflammation Immunology
Russian Federation, 106, Pervomayskaya str., Yekaterinburg, 620049References
- Гусев Е.Ю., Журавлева Ю.А., Зотова Н.В., Соломатина Л.В., Зубова Т.Э., Бражников А.Ю., Паньшина Е.В., Лазарева М.А. Острое и хроническое системное воспаление: сравнительный анализ // Вестник Уральской медицинской академической науки, 2013. № 2. С. 98-103. [Gusev Е.Yu., Zhuravleva J.А., Zotova N.V., Solomatina L.V., Zubova T.E., Brazhnikov A.Yu., Panshina Е.V., Lazareva М.А. Acute and chronic systemic inflammation: comparative analysis. Vestnik Uralskoy meditsinskoy akademicheskoy nauki = Journal of Ural Medical Academic Science, 2013, no. 2, pp. 98-103. (In Russ.)]
- Dimitroulas T., Hodson J., Sandoo A., Smith J., Kitas G.D. Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation. Arthritis Res Ther., 2017, Vol. 19, no. 1, 32. doi: 10.1186/s13075-017-1232-1.
- Gusev E., Zhuravleva Y. Inflammation: A new look at an old problem. Int. J. Mol. Sci., 2022, Vol. 23, no. 9, 4596. doi: 10.3390/ijms23094596.
- Lasek-Bal A., Jedrzejowska-Szypulka H., Student S., Warsz-Wianecka A., Zareba K., Puz P., Bal W., Pawletko K., Lewin-Kowalik J. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis. J. Physiol. Pharmacol., 2019, Vol. 70, no. 2. doi: 10.26402/jpp.2019.2.04.
- Markoulaki D., Kostikas K., Papatheodorou G., Koutsokera A., Alchanatis M., Bakakos P., Gourgoulianis K.I., Roussos C., Koulouris N.G., Loukides S. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Eur. J. Intern. Med., 2011, Vol. 22, no. 1, pp. 103-107.
- Metz C.E. Fundamental ROC Analysis. Handbook of Medical Imaging, Volume 1. Physics and Psychophysics.Ed. Richard L. van Metter, Jacob Beutel, Harold L. Kundel., 2000, рр. 751-770.
- Póvoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., Sabino H. C-reactive protein as a marker of infection in critically ill patients. Clin. Microbiol. Infect., 2005, Vol. 11, no. 2, pp.101-108.
- Qu R., Hu L., Ling Y., Hou Y., Fang H., Zhang H., Liang S., He Z., Fang M., Li J., Li X., Chen C. C-reactive protein concentration as a risk predictor of mortality in intensive care unit: a multicenter, prospective, observational study. BMC Anesthesiol., 2020, Vol. 20, no. 1, 292. doi: 10.1186/s12871-020-01207-3.
- Smok B., Domagalski K., Pawłowska M. Diagnostic and prognostic value of IL-6 and sTREM-1 in SIRS and sepsis in children. Mediators Inflamm., 2020, Vol. 2020, 8201585. doi: 10.1155/2020/8201585.
- Solus J.F., Chung C.P., Oeser A., Li C., Rho Y.H., Bradley K.M., Kawai V.K., Smith J.R., Stein C.M. Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis. Clin. Rheumatol., 2015, Vol. 34, no. 8, pp. 1375-1382.
- Zhang J., Chen L., Delzell E., Muntner P., Hillegass W.B., Safford M.M., Millan I.Y., Crowson C.S., Curtis J.R. The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Ann. Rheum. Dis., 2014, Vol. 73, no. 7, pp. 1301-1308.
- Zhang W., Tang Z., Shi Y., Ji L., Chen X., Chen Y., Wang X., Wang M., Wang W., Li D. Association between gamma-glutamyl transferase, total bilirubin and systemic lupus erythematosus in chinese women. Front. Immunol., 2021, Vol. 12, 682400. doi: 10.3389/fimmu.2021.682400.
- Zotova N.V., Chereshnev V.A., Gusev E.Yu. Systemic inflammation: methodological approaches to identification of the common pathological process. PLoS One, 2016, Vol. 11, no. 5, e0155138. doi: 10.1371/journal.pone.0155138.
- Zotova N.V., Zhuravleva Y.A., Zubova T.E., Gusev E.Y. Integral estimation of systemic inflammatory response under sepsis. Gen. Physiol. Biophys., 2020, Vol. 39, no. 1, pp. 13-26.
Supplementary files
